Guggenheim Capital’s AfterNext HealthTech Acquisition Corp AFTR Stock Holding History

Guggenheim Capital’s Portfolio AFTR Stock Details AFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,792,000	Closed	-$18.6M	–	1947
2023 Q2	$18.6M	Hold	1,792,000	–	–	0.15%	135
2023 Q1	$18.3M	Hold	1,792,000	–	–	0.15%	138
2022 Q4	$18M	Sell	1,792,000 -6,300	-0.4%	-$62.4K	0.16%	148
2022 Q3	$17.6M	Sell	1,798,300 -1,862,500	-51%	-$18.1M	0.16%	145
2022 Q2	$35.5M	Sell	3,660,800 -64,200	-2%	-$622K	0.28%	64
2022 Q1	$36.1M	Hold	3,725,000	–	–	0.22%	85
2021 Q4	$36.3M	Buy	+3,725,000	New	+$36.1M	0.19%	102

Guggenheim Capital's AFTR Position: Q3 2023 in Review

Guggenheim Capital sold out of AfterNext HealthTech Acquisition Corp (AFTR) in Q3 2023, closing a stake of 1,792,000 shares — an estimated $18.6M sold.

Guggenheim Capital first reported a position in AFTR in Q4 2021 and held it in 7 quarters. The position peaked at $36.3M in Q4 2021. 0 funds tracked by Wall St. Rank hold AFTR as of Q3 2023.

Guggenheim Capital reported no remaining AfterNext HealthTech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
Guggenheim Capital sold 1,792,000 AfterNext HealthTech Acquisition Corp shares in Q3 2023, an estimated $18.6M.
Guggenheim Capital first reported a position in AfterNext HealthTech Acquisition Corp in Q4 2021 and held it in 7 quarters.
Guggenheim Capital's AfterNext HealthTech Acquisition Corp position peaked at $36.3M in Q4 2021.
0 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp as of Q3 2023.

Based on Guggenheim Capital's 13F filing for Q3 2023, filed 14 Nov 2023.